Transcutaneous electrical stimulation of the trigeminal nerve for ADHD
Closed for comments This consultation ended on at Request commenting lead permission
3 Committee considerations
The evidence
3.1 NICE did a rapid review of the published literature on the efficacy and safety of this procedure. This comprised a comprehensive literature search and detailed review of the evidence from 3 sources, which was discussed by the committee. The evidence included 1 randomised controlled trial (with 1 secondary analysis) and 1 open-label trial. It is presented in the summary of key evidence section in the interventional procedures overview.
3.2 The professional experts and the committee considered the key efficacy outcomes to be: improved quality of life, reduced symptoms and reduced need for medication.
3.3 The professional experts and the committee considered the key safety outcomes to be: pain, skin irritation, negative effect on cognitive function and worsening of symptoms.
3.4 Patient commentary was sought but none was received.
Committee comments
3.5 The committee was informed that the procedure is primarily indicated for people for whom medication is unsuitable.
3.6 The device has regulatory approval for use in people aged 7 and over, but all the evidence that the committee considered was from children.
3.7 The committee was informed that treatment usually takes place at night and that a course of treatment may need to be repeated.
Tom Clutton-Brock
Chair, interventional procedures advisory committee
July, 2022
ISBN:
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions